Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Antifungal susceptibility profiles of rare ascomycetous yeasts.

Pérez-Hansen A, Lass-Flörl C, Lackner M; Rare Yeast Study Group .

J Antimicrob Chemother. 2019 Jun 15. pii: dkz231. doi: 10.1093/jac/dkz231. [Epub ahead of print]

PMID:
31203366
2.

CBP/p300 drives the differentiation of Regulatory T cells through transcriptional and non-transcriptional mechanisms.

Castillo J, Wu E, Lowe C, Srinivasan S, McCord R, Wagle MC, Jayakar S, Gonzalez Edick M, Eastham-Anderson J, Liu B, Hutchinson KE, Jones W, Stokes MP, Tarighat SS, Holcomb T, Glibicky A, Romero FA, Magnuson S, Huang SA, Plaks V, Giltnane JM, Lackner MR, Mounir Z.

Cancer Res. 2019 Jun 10. pii: canres.3622.2018. doi: 10.1158/0008-5472.CAN-18-3622. [Epub ahead of print]

PMID:
31182547
3.

Cryptic species of Aspergillus section Terrei display essential physiological features to cause infection and are similar in their virulence potential in Galleria mellonella.

Lackner M, Obermair J, Naschberger V, Raschbichler LM, Kandelbauer C, Pallua J, Metzlaff J, Furxer S, Lass-Flörl C, Binder U.

Virulence. 2019 Dec;10(1):542-554. doi: 10.1080/21505594.2019.1614382.

PMID:
31169442
4.

The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B.

Stavrou AA, Lackner M, Lass-Flörl C, Boekhout T.

FEMS Yeast Res. 2019 Jun 1;19(4). pii: foz037. doi: 10.1093/femsyr/foz037.

PMID:
31158288
5.

"Enhanced acquisition of antibiotic-resistant intestinal E. coli during the first year of life assessed in a prospective cohort study".

Hetzer B, Orth-Höller D, Würzner R, Kreidl P, Lackner M, Müller T, Knabl L, Geisler-Moroder DR, Mellmann A, Sesli Ö, Holzknecht J, Noce D, Boonpala O, Akarathum N, Chotinaruemol S, Prelog M, Oberdorfer P.

Antimicrob Resist Infect Control. 2019 May 20;8:79. doi: 10.1186/s13756-019-0522-6. eCollection 2019.

6.

A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.

Piskol R, Huw L, Sergin I, Kljin C, Modrusan Z, Kim D, Kljavin N, Tam R, Patel R, Burton J, Penuel E, Qu X, Koeppen H, Sumiyoshi T, de Sauvage F, Lackner MR, de Sousa E Melo F, Kabbarah O.

Clin Cancer Res. 2019 Apr 19. doi: 10.1158/1078-0432.CCR-18-3032. [Epub ahead of print]

PMID:
31004000
7.

Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples from multicenter (2015-2018): Potential prognostic values of genotyping and sequencing of PDR1.

Arastehfar A, Daneshnia F, Zomorodian K, Najafzadeh MJ, Khodavaisy S, Zarrinfar H, Hagen F, Shahrabadi ZZ, Lackner M, Mirhendi H, Salehi M, Roudbary M, Pan W, Kostrzewa M, Boekhout T.

Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02503-18. doi: 10.1128/AAC.02503-18. [Epub ahead of print]

8.

Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients.

Aigner M, Wanner M, Kreidl P, Lass-Flörl C, Lackner M.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00138-19. doi: 10.1128/AAC.00138-19. Print 2019 Jun.

PMID:
30936100
9.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

10.

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing.

Spettel K, Barousch W, Makristathis A, Zeller I, Nehr M, Selitsch B, Lackner M, Rath PM, Steinmann J, Willinger B.

PLoS One. 2019 Jan 10;14(1):e0210397. doi: 10.1371/journal.pone.0210397. eCollection 2019.

11.

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®.

Seidel D, Meißner A, Lackner M, Piepenbrock E, Salmanton-García J, Stecher M, Mellinghoff S, Hamprecht A, Durán Graeff L, Köhler P, Cheng MP, Denis J, Chedotal I, Chander J, Pakstis DL, Los-Arcos I, Slavin M, Montagna MT, Caggiano G, Mares M, Trauth J, Aurbach U, Vehreschild MJGT, Vehreschild JJ, Duarte RF, Herbrecht R, Wisplinghoff H, Cornely OA.

Crit Rev Microbiol. 2019 Feb;45(1):1-21. doi: 10.1080/1040841X.2018.1514366. Epub 2019 Jan 10. Erratum in: Crit Rev Microbiol. 2019 Feb 18;:1.

PMID:
30628529
12.

Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort.

Chen X, Chang CW, Spoerke JM, Yoh KE, Kapoor V, Baudo C, Aimi J, Yu M, Liang-Chu MMY, Suttmann R, Huw LY, Gendreau S, Cummings C, Lackner MR.

Clin Cancer Res. 2019 Apr 1;25(7):2254-2263. doi: 10.1158/1078-0432.CCR-18-1593. Epub 2019 Jan 7.

PMID:
30617129
13.

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.

Joseph JD, Darimont B, Zhou W, Arrazate A, Young A, Ingalla E, Walter K, Blake RA, Nonomiya J, Guan Z, Kategaya L, Govek SP, Lai AG, Kahraman M, Brigham D, Sensintaffar J, Lu N, Shao G, Qian J, Grillot K, Moon M, Prudente R, Bischoff E, Lee KJ, Bonnefous C, Douglas KL, Julien JD, Nagasawa JY, Aparicio A, Kaufman J, Haley B, Giltnane JM, Wertz IE, Lackner MR, Nannini MA, Sampath D, Schwarz L, Manning HC, Tantawy MN, Arteaga CL, Heyman RA, Rix PJ, Friedman L, Smith ND, Metcalfe C, Hager JH.

Elife. 2019 Jan 7;8. pii: e44851. doi: 10.7554/eLife.44851.

14.

Bioprocess Engineering Aspects of Sustainable Polyhydroxyalkanoate Production in Cyanobacteria.

Kamravamanesh D, Lackner M, Herwig C.

Bioengineering (Basel). 2018 Dec 18;5(4). pii: E111. doi: 10.3390/bioengineering5040111. Review.

15.

Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples.

Arastehfar A, Fang W, Daneshnia F, Al-Hatmi AM, Liao W, Pan W, Khan Z, Ahmad S, Rosam K, Lackner M, Lass-Flörl C, Hagen F, Boekhout T.

Future Microbiol. 2019 Jan;14:33-45. doi: 10.2217/fmb-2018-0227. Epub 2018 Dec 12.

16.

High percentage of microbial colonization of osteosynthesis material in clinically unremarkable patients.

Knabl L, Kuppelwieser B, Mayr A, Posch W, Lackner M, Coraҫa-Huber D, Danita A, Blauth M, Lass-Flörl C, Orth-Höller D.

Microbiologyopen. 2019 Mar;8(3):e00658. doi: 10.1002/mbo3.658. Epub 2018 Dec 3.

17.

Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology.

Okrah K, Tarighat S, Liu B, Koeppen H, Wagle MC, Cheng G, Sun C, Dey A, Chang MT, Sumiyoshi T, Mounir Z, Cummings C, Hampton G, Amler L, Fridlyand J, Hegde PS, Turley SJ, Lackner MR, Huang SM.

NPJ Precis Oncol. 2018 Nov 15;2:25. doi: 10.1038/s41698-018-0068-8. eCollection 2018.

18.

Increased carbohydrate production from carbon dioxide in randomly mutated cells of cyanobacterial strain Synechocystis sp. PCC 6714: Bioprocess understanding and evaluation of productivities.

Kamravamanesh D, Slouka C, Limbeck A, Lackner M, Herwig C.

Bioresour Technol. 2019 Feb;273:277-287. doi: 10.1016/j.biortech.2018.11.025. Epub 2018 Nov 9.

PMID:
30448679
19.

Identification and regulation of the long non-coding RNA Heat2 in heart failure.

Boeckel JN, Perret MF, Glaser SF, Seeger T, Heumüller AW, Chen W, John D, Kokot KE, Katus HA, Haas J, Lackner MK, Kayvanpour E, Grabe N, Dieterich C, von Haehling S, Ebner N, Hünecke S, Leuschner F, Fichtlscherer S, Meder B, Zeiher AM, Dimmeler S, Keller T.

J Mol Cell Cardiol. 2019 Jan;126:13-22. doi: 10.1016/j.yjmcc.2018.11.004. Epub 2018 Nov 13.

PMID:
30445017
20.

YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries.

Arastehfar A, Fang W, Pan W, Lackner M, Liao W, Badiee P, Zomorodian K, Badali H, Hagen F, Lass-Flörl C, Boekhout T.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):112-119. doi: 10.1016/j.diagmicrobio.2018.09.007. Epub 2018 Sep 21.

21.

Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.

Lackner M, Birch M, Naschberger V, Grässle D, Beckmann N, Warn P, Gould J, Law D, Lass-Flörl C, Binder U.

J Antimicrob Chemother. 2018 Nov 1;73(11):3068-3073. doi: 10.1093/jac/dky329.

PMID:
30351438
22.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

23.

Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers.

Wilson TR, Udyavar AR, Chang CW, Spoerke JM, Aimi J, Savage HM, Daemen A, O'Shaughnessy JA, Bourgon R, Lackner MR.

Mol Cancer Res. 2019 Jan;17(1):97-108. doi: 10.1158/1541-7786.MCR-18-0619. Epub 2018 Aug 31.

PMID:
30171174
24.

Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.

Vatanshenassan M, Boekhout T, Lass-Flörl C, Lackner M, Schubert S, Kostrzewa M, Sparbier K.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00420-18. doi: 10.1128/JCM.00420-18. Print 2018 Sep.

25.

A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria.

Lass-Flörl C, Mayr A, Aigner M, Lackner M, Orth-Höller D.

Infection. 2018 Oct;46(5):701-704. doi: 10.1007/s15010-018-1170-0. Epub 2018 Jul 3.

26.

Increased poly-β-hydroxybutyrate production from carbon dioxide in randomly mutated cells of cyanobacterial strain Synechocystis sp. PCC 6714: Mutant generation and characterization.

Kamravamanesh D, Kovacs T, Pflügl S, Druzhinina I, Kroll P, Lackner M, Herwig C.

Bioresour Technol. 2018 Oct;266:34-44. doi: 10.1016/j.biortech.2018.06.057. Epub 2018 Jun 20.

PMID:
29957289
27.

Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA.

Clark TA, Chung JH, Kennedy M, Hughes JD, Chennagiri N, Lieber DS, Fendler B, Young L, Zhao M, Coyne M, Breese V, Young G, Donahue A, Pavlick D, Tsiros A, Brennan T, Zhong S, Mughal T, Bailey M, He J, Roels S, Frampton GM, Spoerke JM, Gendreau S, Lackner M, Schleifman E, Peters E, Ross JS, Ali SM, Miller VA, Gregg JP, Stephens PJ, Welsh A, Otto GA, Lipson D.

J Mol Diagn. 2018 Sep;20(5):686-702. doi: 10.1016/j.jmoldx.2018.05.004. Epub 2018 Jun 22.

28.

Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.

Maurer E, Hörtnagl C, Lackner M, Grässle D, Naschberger V, Moser P, Segal E, Semis M, Lass-Flörl C, Binder U.

Med Mycol. 2019 Apr 1;57(3):351-362. doi: 10.1093/mmy/myy042.

29.

A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.

Wagle MC, Kirouac D, Klijn C, Liu B, Mahajan S, Junttila M, Moffat J, Merchant M, Huw L, Wongchenko M, Okrah K, Srinivasan S, Mounir Z, Sumiyoshi T, Haverty PM, Yauch RL, Yan Y, Kabbarah O, Hampton G, Amler L, Ramanujan S, Lackner MR, Huang SA.

NPJ Precis Oncol. 2018 Mar 7;2(1):7. doi: 10.1038/s41698-018-0051-4. eCollection 2018.

30.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

31.

Scedosporium and Lomentospora: an updated overview of underrated opportunists.

Ramirez-Garcia A, Pellon A, Rementeria A, Buldain I, Barreto-Bergter E, Rollin-Pinheiro R, de Meirelles JV, Xisto MIDS, Ranque S, Havlicek V, Vandeputte P, Govic YL, Bouchara JP, Giraud S, Chen S, Rainer J, Alastruey-Izquierdo A, Martin-Gomez MT, López-Soria LM, Peman J, Schwarz C, Bernhardt A, Tintelnot K, Capilla J, Martin-Vicente A, Cano-Lira J, Nagl M, Lackner M, Irinyi L, Meyer W, de Hoog S, Hernando FL.

Med Mycol. 2018 Apr 1;56(suppl_1):102-125. doi: 10.1093/mmy/myx113. Review.

PMID:
29538735
32.

Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice.

Lackner M, Rambach G, Jukic E, Sartori B, Fritz J, Seger C, Hagleitner M, Speth C, Lass-Flörl C.

Med Mycol. 2018 Aug 1;56(6):703-710. doi: 10.1093/mmy/myx109.

PMID:
29228287
33.

Direct detection of Exophiala and Scedosporium species in sputa of patients with cystic fibrosis.

Chen M, Kondori N, Deng S, Gerrits van den Ende AHG, Lackner M, Liao W, de Hoog GS.

Med Mycol. 2018 Aug 1;56(6):695-702. doi: 10.1093/mmy/myx108.

PMID:
29228273
34.

Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase.

Caramalho R, Tyndall JDA, Monk BC, Larentis T, Lass-Flörl C, Lackner M.

Sci Rep. 2017 Nov 21;7(1):15898. doi: 10.1038/s41598-017-16123-9.

35.

Impact of Morphological Sectors on Antifungal Susceptibility Testing and Virulence Studies.

Jukic E, Blatzer M, Binder U, Mayr L, Lass-Flörl C, Lackner M.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00755-17. doi: 10.1128/AAC.00755-17. Print 2017 Dec.

36.

Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience.

Lass-Flörl C, Aigner M, Nachbaur D, Eschertzhuber S, Bucher B, Geltner C, Bellmann R, Lackner M, Orth-Höller D, Würzner R, Weiss G, Glodny B.

Infection. 2017 Dec;45(6):867-875. doi: 10.1007/s15010-017-1072-6. Epub 2017 Sep 27.

37.

High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing.

Guan Y, Mayba O, Sandmann T, Lu S, Choi Y, Darbonne WC, Leveque V, Ryner L, Humke E, Tam NWR, Sujathasarma S, Cheung A, Bourgon R, Lackner MR, Wang Y.

J Mol Diagn. 2017 Nov;19(6):921-932. doi: 10.1016/j.jmoldx.2017.08.001. Epub 2017 Sep 1.

PMID:
28867605
38.

A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors.

Leong S, Moss RA, Bowles DW, Ware JA, Zhou J, Spoerke JM, Lackner MR, Shankar G, Schutzman JL, van der Noll R, Voest EE, Schellens JHM.

Oncologist. 2017 Dec;22(12):1491-1499. doi: 10.1634/theoncologist.2017-0090. Epub 2017 Aug 10.

39.

The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population.

Wilson TR, Yu J, Lu X, Spoerke JM, Xiao Y, O'Brien C, Savage HM, Huw LY, Zou W, Koeppen H, Forrest WF, Fridlyand J, Fu L, Tam R, Schleifman EB, Sumiyoshi T, Molinero L, Hampton GM, O'Shaughnessy JA, Lackner MR.

NPJ Breast Cancer. 2016 Jul 13;2:16022. doi: 10.1038/npjbcancer.2016.22. eCollection 2016.

40.

N-Chlorotaurine, a Promising Future Candidate for Topical Therapy of Fungal Infections.

Nagl M, Arnitz R, Lackner M.

Mycopathologia. 2018 Feb;183(1):161-170. doi: 10.1007/s11046-017-0175-z. Epub 2017 Jul 12. Review.

41.

Photosynthetic poly-β-hydroxybutyrate accumulation in unicellular cyanobacterium Synechocystis sp. PCC 6714.

Kamravamanesh D, Pflügl S, Nischkauer W, Limbeck A, Lackner M, Herwig C.

AMB Express. 2017 Dec;7(1):143. doi: 10.1186/s13568-017-0443-9. Epub 2017 Jul 6.

42.

On the likelihood of single-peaked preferences.

Lackner ML, Lackner M.

Soc Choice Welfare. 2017;48(4):717-745. doi: 10.1007/s00355-017-1033-0. Epub 2017 Mar 7.

43.

A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.

Risslegger B, Zoran T, Lackner M, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Houbraken J, Uzun O, Edlinger M, Fuente S, Lass-Flörl C.

Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13.

44.

Bactericidal and Fungicidal Activity of N-Chlorotaurine Is Enhanced in Cystic Fibrosis Sputum Medium.

Gruber M, Moser I, Nagl M, Lackner M.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02527-16. doi: 10.1128/AAC.02527-16. Print 2017 May.

45.

Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?

Xisto MI, Caramalho RD, Rocha DA, Ferreira-Pereira A, Sartori B, Barreto-Bergter E, Junqueira ML, Lass-Flörl C, Lackner M.

J Antimicrob Chemother. 2017 Apr 1;72(4):988-992. doi: 10.1093/jac/dkw558.

PMID:
28065893
46.

Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis.

Martin-Vicente A, Guarro J, González GM, Lass-Flörl C, Lackner M, Capilla J.

J Antimicrob Chemother. 2017 Apr 1;72(4):1118-1122. doi: 10.1093/jac/dkw532.

PMID:
28031271
47.

Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples.

Springer J, Lackner M, Ensinger C, Risslegger B, Morton CO, Nachbaur D, Lass-Flörl C, Einsele H, Heinz WJ, Loeffler J.

J Med Microbiol. 2016 Dec;65(12):1414-1421. doi: 10.1099/jmm.0.000375. Epub 2016 Oct 24.

PMID:
27902424
48.

The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy.

Cummings CA, Peters E, Lacroix L, Andre F, Lackner MR.

Clin Transl Sci. 2016 Dec;9(6):283-292. doi: 10.1111/cts.12429. Epub 2016 Nov 15. No abstract available.

49.

Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers.

Kim D, Choi Y, Ireland J, Foreman O, Tam RN, Patel R, Schleifman EB, Motlhabi M, French D, Wong CV, Peters E, Molinero L, Raja R, Amler LC, Hampton GM, Lackner MR, Kabbarah O.

PLoS One. 2016 Nov 15;11(11):e0165856. doi: 10.1371/journal.pone.0165856. eCollection 2016.

50.

Commercial Molecular Tests for Fungal Diagnosis from a Practical Point of View.

Lackner M, Lass-Flörl C.

Methods Mol Biol. 2017;1508:85-105. Review.

PMID:
27837499

Supplemental Content

Loading ...
Support Center